47 results on '"Ye, Xin‐Ping"'
Search Results
2. ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
3. Dual transformation therapy for giant hepatocellular carcinoma: Two case reports and review of literature
4. Case Report: A case of hepatocellular carcinoma with aberrant right hepatic artery treated with transarterial chemoembolization and infusion chemotherapy separately to bilobar lesion combining with systemic therapies and sequential hepatectomy
5. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms
6. Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration
7. Characterization of hepatocarcinogenesis by transcriptome and exome sequencing via chronic HBV X expression and aflatoxin B1 exposure in immortal hepatic cell
8. The impact of predation on population dynamics of the Crested Ibis in the Qinling Mountains, Shaanxi, central China
9. The impact of predation on population dynamics of the Crested Ibis in the Qinling Mountains, Shaanxi, central China.
10. Clinical Significance and Potential Mechanisms of ATP Binding Cassette Subfamily C Genes in Hepatocellular Carcinoma
11. CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis
12. Prognostic Signature based on Transcriptome Characteristics of the C-C Motif Chemokine Receptor Genes in Hepatocellular Carcinoma and Validation
13. Post‐release dispersal and breeding site suitability of reintroduced populations of the Crested Ibis in Shaanxi Province, China
14. Oncogene UBE2I enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinoma
15. Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma
16. SOX4 as biomarker in hepatitis B virus-associated hepatocellular carcinoma
17. Additional file 2 of Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms
18. Additional file 3 of Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms
19. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms
20. [Untitled]Biomechanics of implanted screws for cervical spine injury
21. [Untitled]Biomechanics of implanted screws for cervical spine injury
22. Functional rehabilitation training following hip replacement
23. ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
24. Bachelor groups in primate multilevel society facilitate gene flow across fragmented habitats
25. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines
26. Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma
27. Bile in bronchi: A case report
28. Novel candidate biomarkers of origin recognition complex 1, 5 and 6 for survival surveillance in patients with hepatocellular carcinoma
29. Comprehensive investigation of p53, p21, nm23, and VEGF expression in hepatitis B virus-related hepatocellular carcinoma overall survival after hepatectomy
30. Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1—a multi-center and multi-biomarker study
31. Should hepatic resection be recommended to patients with hepatocellular carcinoma and portal vein invasion?
32. On the sustainability of a reintroduced Crested Ibis population in Qinling Mountains, Shaanxi, Central China
33. Efficacy trend of hepatic resection for hepatocellular carcinoma with large multinodular tumor or macrovascular invasion.
34. On the sustainability of a reintroduced Crested Ibis population in Qinling Mountains, Shaanxi, Central China.
35. Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension
36. Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma
37. Clinicopathologic Characteristics and Prognoses for Multicentric Occurrence and Intrahepatic Metastasis in Synchronous Multinodular Hepatocellular Carcinoma Patients
38. Comparative proteomic analysis of differentiating multicentric occurrence and intrahepatic metastasis in multinodular hepatocellular carcinoma
39. Clonal origin of multinodular hepatocellular carcinoma: identification and clinical implications
40. Effect of preoperative chemotherapy on the expression of human 8-oxoGuanine DNA glycosylase-1 and poly ADP-ribose polymerase in hepatocellular carcinoma
41. Should hepatic resection be recommended to patients with hepatocellular carcinoma and portal vein invasion?
42. CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27 kip1 Axis.
43. Oncogene UBE2I enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinoma.
44. [Comparative proteomic approach in differentiating multicentric occurrence and intrahepatic metastasis in multinodular hepatocellular carcinomas].
45. [Diagnosis and treatment of primary clear cell carcinoma of the liver].
46. [Application of polymerase chain reaction with confronting two-pair primers in aldehyde dehydrogenase-2 typing].
47. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to hepatocellular carcinoma].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.